The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
Travel, Accommodations, Expenses - Guardant Health
Blood-based tumor mutational burden from circulating tumor DNA (ctDNA) across advanced solid malignancies using a commercially available liquid biopsy assay.
 
Leylah Drusbosky
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
Travel, Accommodations, Expenses - Guardant Health
 
Mehmet Asim Bilen
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Calithera Biosciences; Eisai; EMD Serono; Exelixis; Exelixis; Genomic Health; Janssen; Nektar; Pfizer; Sanofi; Seagen
Research Funding - Advanced Accelerator Applications (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Genentech/Roche (Inst); Genome & Company (Inst); Incyte (Inst); Nektar (Inst); Peloton Therapeutics (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Seagen (Inst); Tricon Pharmaceuticals (Inst); Xencor (Inst)
 
Georges Azzi
Stock and Other Ownership Interests - Aptose Biosciences; Cellectis; CohBar; CytomX Therapeutics; CytomX Therapeutics; FibroGen; Global Blood Therapeutics; Guardant Health; Halozyme; Illumina; InVitae; Sangamo Therapeutics; TG Therapeutics; Zymeworks
Honoraria - Abbvie; Blueprint Medicines; Bristol-Myers Squibb; Gilead Sciences (Inst); Pfizer
Speakers' Bureau - Guardant Health; Natera
Research Funding - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Mirati Therapeutics (Inst); Natera (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Abbvie; Bristol-Myers Squibb; Mirati Therapeutics
 
Pedro C. Barata
Consulting or Advisory Role - Bayer; BMS; Caris Life Sciences; Clovis Oncology (Inst); Dendreon (Inst); Eisai; EMD Serono; Pfizer
Research Funding - Blue Earth Diagnostics (Inst)
 
Patrick M Boland
Consulting or Advisory Role - Bayer
Research Funding - Abbvie (Inst); Athenex (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Ipsen (Inst); Merck (Inst)
 
Alan Haruo Bryce
Honoraria - Astellas Pharma; Bayer
Travel, Accommodations, Expenses - Clovis Oncology (Inst); Phosplatin Therapeutics (Inst)
 
Young Kwang Chae
Consulting or Advisory Role - AstraZeneca; Biodesix; Boehringer Ingelheim; Counsyl; Foundation Medicine; Guardant Health; Hanmi; Immuneoncia; Lilly; Roche/Genentech; Takeda; Tempus
Speakers' Bureau - AstraZeneca; Genentech/Roche; Lilly; Merck
Research Funding - Abbvie; Biodesix; Bristol-Myers Squibb; Freenome; Lexent Bio
Travel, Accommodations, Expenses - Hanmi
 
Jeremy Meyer Force
Stock and Other Ownership Interests - Genomic Health
Consulting or Advisory Role - Exact Sciences
Speakers' Bureau - Genomic Health
 
Martin Gutierrez
Stock and Other Ownership Interests - Cota Healthcare
Honoraria - Foundation Medicine; Guardant Health
Consulting or Advisory Role - Eisai
Speakers' Bureau - Bristol-Myers Squibb; Lilly; Merck
Research Funding - Acerta Pharma (Inst); Arcus Biosciences (Inst); Array BioPharma (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Checkpoint Therapeutics (Inst); Compass Therapeutics (Inst); Constellation Pharmaceuticals (Inst); Cyteir (Inst); Eisai (Inst); EMD Serono (Inst); EMD Serono (Inst); Fate Therapeutics (Inst); GlaxoSmithKline (Inst); GSB Pharma (Inst); Incyte (Inst); Infinity Pharmaceuticals (Inst); Johnson & Johnson (Inst); MedImmune (Inst); Merck (Inst); Moderna Therapeutics (Inst); NextCure (Inst); Pfizer (Inst); Pharmacyclics (Inst); Regeneron (Inst); Roche/Genentech (Inst); Sanofi (Inst); Seagen (Inst); Silenseed (Inst); Synlogic (Inst); Tesaro (Inst); Vedanta Biosciences (Inst)
Travel, Accommodations, Expenses - Guardant Health
 
Pashtoon Murtaza Kasi
Consulting or Advisory Role - AstraZeneca; Foundation Medicine; Ipsen (Inst); MSD Oncology; Natera; Taiho Pharmaceutical (Inst)
Research Funding - Advanced Accelerator Applications (Inst); Array BioPharma (Inst); Boston Scientific (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Tersera (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Hiba I. Dada
Employment - Gilead Sciences (I); Guardant Health; Illumina
Stock and Other Ownership Interests - Gilead Sciences (I); Guardant Health; Illumina
 
Caroline Weipert
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
Travel, Accommodations, Expenses - Guardant Health
 
Chuck Hensel
No Relationships to Disclose
 
Lesli A. Kiedrowski
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
 
Che-Yu Lee
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
 
Martina Lefterova
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
Consulting or Advisory Role - Personalis
 
David R. Gandara
Honoraria - AstraZeneca; CBPartners; MJH Life Sciences
Consulting or Advisory Role - Amgen; AstraZeneca (Inst); Boehringer Ingelheim; Guardant Health (Inst); Inivata; IO Biotech (Inst); Lilly (Inst); Merck; OncoCyte (Inst); Roche/Genentech
Research Funding - Amgen (Inst); Merck (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim